These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 286125)

  • 21. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
    Fisher B; Linta J; Hanlon J; Saffer E
    J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
    [No Abstract]   [Full Text] [Related]  

  • 22. A bladder tumor model response to immunotherapy.
    deKernion JB; Ramming KP; Fraser K
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further observations on the inhibition of tumor growth by C. parvum with cyclophosphamide. VII. Effect of treatment prior to primary tumor removal on the growth of distant tumor.
    Fisher B; Gebhardt M; Saffer E
    Cancer; 1979 Feb; 43(2):451-8. PubMed ID: 421172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
    Stiffel C; Chalvet H; Mazurek C
    Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C; Stiffel C; Chalvet H; Biozzi G
    C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
    Suit HD; Sedlacek R; Silobrcic V
    Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Corynebacterium parvum treatment of mice with sarcoma growing in normal or irradiated tissue.
    Suit HD; Sedlacek R; Echteler S
    Cancer Res; 1977 Nov; 37(11):4233-4. PubMed ID: 908052
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of Corynebacterium parvum and chronic Toxoplasma infection on metastatic brain tumors in mice.
    Conley FK
    J Natl Cancer Inst; 1979 Nov; 63(5):1237-44. PubMed ID: 291750
    [No Abstract]   [Full Text] [Related]  

  • 32. Response of tumors to biologic modifiers and chemotherapeutic agents.
    Katsuoka Y; deKernion JB
    Tokai J Exp Clin Med; 1983 May; 8(2):175-85. PubMed ID: 6658848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysozyme levels and macrophage content of tumor tissue in C3H mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum.
    Mendiondo O; Suit H; Fixler H
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):829-34. PubMed ID: 711553
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors.
    Branunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1978 May; 62(5):727-36. PubMed ID: 657158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1979 Oct; 39(10):3812-5. PubMed ID: 476617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK; Lacour F; Hue G
    Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Local Corynebacterium parvum therapy in early breast cancer.
    Ackroyd NW; Boak JL
    Br J Surg; 1976 Aug; 63(8):659. PubMed ID: 953485
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum.
    Maruyama Y; Coleman MS
    Cancer Res; 1978 Jun; 38(6):1617-20. PubMed ID: 647675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.